Biotech

All Articles

8 months after a $213M fundraise, genetics editor Tome creates cuts

.After increasing $213 thousand in 2023-- among the year's largest exclusive biotech rounds-- Tome B...

BioMarin builds officer group along with biotech veterinarians-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, firings a...

Biopharma Q2 VC reached highest degree since '22, while M&ampA slowed down

.Equity capital financing into biopharma cheered $9.2 billion around 215 deals in the second one-fou...

Bicara, Zenas find IPOs to drive late-phase assets toward market

.Bicara Therapeutics as well as Zenas Biopharma have offered new incentive to the IPO market along w...

Genentech to shut cancer immunology study division

.Genentech is going to shut its own cancer cells immunology investigation team, and also device mind...

Kezar falls solid growth yet to verify its own worth in phase 1 trial

.Kezar Life Sciences is falling its unpromising stage 1 sound lump drug as the biotech goes all-in o...

Acelyrin loses izokibep, dismisses 3rd of staff

.Regardless of izokibep preserving its newly found winning streak in the medical clinic, Acelyrin is...

Rivus' stage 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its own fat-busting, muscle-sparing medi...

Ovid halts preclinical job, IV course after soticlestat neglect

.Ovid Therapy currently disclosed last month that it was actually trimming back its head count as th...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has opened up a $700 million R&ampD facility in the Boston Port, enhancing its RNA and DN...